More reports from the EAU “Update on Prostate Cancer”

Dr. Zachary Klaassen and UroToday have provided us with four more interesting summaries of presentations by faculty at the European Association for Urology (EAU)’s meeting in Vienna last weekend. … READ MORE …

Artificial intelligence and the personalization of cancer therapy

It appears that the ability of Watson to revolutionize the treatment of cancer and provide personalized information that would substantially improve the management of cancer for individual patients may have been over-hyped (click here).

FDA approves CAR T-cell therapy for treatment of acute lymphoblastic leukemia

Within the past few hours, the US Food and Drug Administration (FDA) has approved the very first form of chimeric antigen receptor (CAR) T-cell therapy for the treatment of cancer — and this is also the first true form of gene therapy to be made available here in the US. … READ MORE …

More on statins and the management of prostate cancer

A recent data analysis for the Danish national health registry systems has once again provided confirmation of a link between statin use and risk of prostate cancer-specific mortality. … READ MORE …

Treating the psychosocial and emotional impact of prostate cancer

It doesn’t take too much reading or direct experience to realize that, to date, we haven’t been very good at meeting the needs of patients with prostate cancer — or their spouses/partners — when it comes to the sociocultural and psychological needs associated with this disorder. … READ MORE …

Genetics, genomics, targeted therapy, and the costs of care

A new paper in a new journal argues that all men diagnosed with advanced forms of prostate cancer should now, routinely, be undergoing tumor and germline DNA profiling … READ MORE …

The benefits of yoga for prostate cancer patients undergoing radiotherapy

A small, but randomized Phase II clinical trial has shown benefits of structured yoga classes for men receiving radiation therapy for the treatment of prostate cancer. … READ MORE …